Premarket Mover: Alzamend Neuro Inc (ALZN) Down 20.86%

Alzamend Neuro Inc (ALZN) has fallen Tuesday morning, with the stock losing -20.86% in pre-market trading to 1.1. ALZN's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, the stock ranks higher than 0% of stocks. Alzamend Neuro Inc has fallen 53.97% over the past month, closing at $2.91 on October 24. During this period of time, the stock fell as low as $1.36 and as high as $3.12. ALZN has an average analyst recommendation of Strong Buy. The company has an average price target of $14.99.

ALZN has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ALZN!

See Full ALZN Report

Alzamend Neuro Inc has a Long-Term Technical rank of 23. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 77% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, ALZN ranks better than 132% of stocks.

Important Dates for Investors in ALZN:

-Alzamend Neuro Inc is set to release earnings on 2023-12-11. Over the last 12 months, the company has reported EPS of $-0.13. -We do not have a set dividend date for Alzamend Neuro Inc at this time. Click Here To Get The Full Report on Alzamend Neuro Inc (ALZN)